Navigation Links
Gladstone scientists identify role of fatty acids in Alzheimer's disease
Date:10/19/2008

Scientists at the Gladstone Institute of Neurological Disease (GIND) and the University of California have found that complete or partial removal of an enzyme that regulates fatty acid levels improves cognitive deficits in a mouse model of Alzheimer's disease (AD). Their findings, which will be published in today's issue of Nature Neuroscience, identified specific fatty acids that may contribute to the disease as well as a novel therapeutic strategy.

AD causes a progressive loss of cognitive functions and results in death. Over 5 million Americans are living with this condition. Although there are treatments to ease the symptoms, these treatments are not very effective and researchers have yet to discover a cure.

"Several different proteins have been implicated in Alzheimer's disease," said Lennart Mucke, M.D., GIND director and senior author of the study, "but we wanted to know more about the potential involvement of lipids and fatty acids."

Fatty acids are rapidly taken up by the brain and incorporated into phospholipids, a class of fats that form the membrane or barrier that shields the content of cells from the external environment. The scientists used a large scale profiling approach ("lipidomics") to compare many different fatty acids in the brains of normal mice with those in a mouse model of Alzheimer's disease that develops memory deficits and many pathological alterations seen in the human condition.

"The most striking change we discovered in the Alzheimer mice was an increase in arachidonic acid and related metabolites in the hippocampus, a memory center that is affected early and severely by Alzheimer's disease," said Rene Sanchez-Mejia, M.D., lead author of the study.

In the brain arachidonic acid is released from phospholipids by an enzyme called group IVA phospholipase A2 (or PLA2). The scientists lowered PLA2 levels in the Alzheimer mice by genetic engineering. Removal or even partial redu
'/>"/>

Contact: Valerie Tucker
vtucker@gladstone.ucsf.edu
415-734-2019
Gladstone Institutes
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gladstone scientists identify single microRNA that controls blood vessel development
2. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
3. Scientists Probe Sepsis Deadly Secrets
4. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
5. Scientists Develop Natural Protection for Stored Foods
6. Scientists detect presence of marburg virus in african fruit bats
7. Scientists Spot Brains Free Will Center
8. Scientists ID Likely Culprit in Popcorn Lung
9. Scientists explain how insulin secreting cells maintain their glucose sensitivity
10. Scripps Research scientists shed new light on how antibodies fight HIV
11. Scientists, physicians present latest findings in personalized cancer treatment and prevention

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Dr. Tom Lintner is embracing the latest t...and keep an ongoing dialogue with patients. Throug...s, Dr. Lintner provides information about his Atl... any questions that patients may have. , ...009 -- A plastic surgeon in Atlanta is taking fu...
(Date:11/24/2009)... The GeoPense World Volunteer Computing Te...pplies the Quantum Monte Carlo method to problems ...olecules important in life science research. This ...tion), Einstein@home (gravity wave detection), and...derway. , (PRWEB) Novembe...
(Date:11/24/2009)... Tattoo Removal Laser Clinic, located in S..., Corporal Jason, with his new modeling career. Th...egins modeling full time in the middle of 2010 is ..., 2009 -- Tattoo Removal Laser Clinic, located in ...a, Corporal Jason, with his new modeling career. T...
(Date:11/24/2009)... Developed by Opticom Data Research, Float...amination of the eye. , N...oatScope is a new hand-held device for self-examin...ous ocular health conditions such as floaters and ...e functioning of the iris., , , FloatScope uses a...
(Date:11/23/2009)....C. November 18, 2009 -- A team of researchers at ...rd University has developed a way to simulate bloo...s. It is the basis of a new tool that may help sur..."Fontan" surgery, which is performed on babies bor...esearchers will present their work next week at th...
Breaking Medicine News(10 mins):Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 2Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 3Health News:GeoPense Announces it has Joined QMC@home Project 2Health News:Tattoo Removal on the Fastest U.S. Marine 2Health News:FloatScope - A New Device for Self-Viewing Eye Floaters 2Health News:New tool for helping pediatric heart surgery 2
...ullivan Recognizes Achievements in Creating New Po...nd Business, MILFORD, Mass., Oct. 22 /PRNewswire-...y announced that it has been awarded the 2007 Mark...and,leadership in liquid chromatography (LC) and a...
...ts cardiovascular risk, as do fruits, veggies, res... News) -- Diets rich in whole grains, fruits, vege... heart woes, new studies show. , In one study, reg...outed the benefits of fruits, veggies and the occa...
...alif., Oct. 22 SuperGen Inc.,(Nasdaq: SUPG ), a ... rapid,development and commercialization of therap...s, today announced that it will release its 2007,t...s, and any revised outlook for the future. A pres...
... Industry Leader Brings Its Affordable Services To...ando Area, FT. LAUDERDALE, Fla., Oct. 22 The Nep...company in the U.S., announces it is now,offering ...rvice in Florida, which includes its headquarters ...
...r 22, 2007 (Oakland, CA) Electronic medical record...s and phone calls to patients and their primary ca...y improve the diagnosis and management of the pati...t study to show that electronic medical records im...
...le,s Antibacterial Hand Sanitizer Lotion Kills MRS...c. (OTC,Bulletin Board: SKVI) (Website: http://ww...may have stopped the recent spread of the Super-Bu...n made,with Invisicare(R), is marketed by Triple-S...
Other Medicine News:Health News:Waters Corporation Receives Market Leadership and Product Innovation Awards 2Health News:Waters Corporation Receives Market Leadership and Product Innovation Awards 3Health News:Whole Grains Do a Heart Good 2Health News:Whole Grains Do a Heart Good 3Health News:SuperGen to Announce 2007 Third Quarter Financial Results October 29, 2007 2Health News:Neptune Society Opens Kissimmee, Florida Office 2Health News:Kaiser Permanente study shows electronic medical records and outreach improve osteoporosis care 2Health News:Kaiser Permanente study shows electronic medical records and outreach improve osteoporosis care 3Health News:Future MRSA Outbreaks in Schools are Preventable! 2Health News:Future MRSA Outbreaks in Schools are Preventable! 3
(Date:11/23/2009)...3/PRNewswire-FirstCall/--WestPharmaceuticalService...iefOperatingOfficerMatthewT.Mullarkeyhasleftthecom...efOperatingOfficerStevenA.Ellers,58,willdeferhispr...agerialcontinuityandsupportfollowingMr.Mullarkey,s...nufacturerofcomponentsandsystemsforinjectabledrugd...
(Date:11/23/2009)....23/PRNewswire/--LigonDiscovery,Inc.,whichusesprop...sagainsthigh-valuetargets,todayannouncedtheappoint...sLigon,sExecutiveChairmanoftheBoard. ,, "I,mver...theBoard,"saidPatrickKleyn,Ligon,schiefexecutiveof...enceinthelifesciencesindustry--particularlyhislead...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--AMICAS,Inc.(Nasdaq: AMC...s,todayannouncedthatitwillhighlightitsenterpriseim...tyofNorthAmerica(RSNA)annualmeetingfromNovember29t...nbooth#7124. ,, (Logo: http://www.newscom.com/c...ationalconversationabouthealthcarereform,thereisan...
Breaking Medicine Technology:Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 3RB Rubber Introduces Environmentally Friendly Antimicrobial Rubber Flooring Products 14602 1RB Rubber Introduces Environmentally Friendly Antimicrobial Rubber Flooring Products 14602 2RB Rubber Introduces Environmentally Friendly Antimicrobial Rubber Flooring Products 14602 3Employers of Any Size Can Now Benefit From Dependent Eligibility Audits Thanks to New Audit Toolkit 60131 1Employers of Any Size Can Now Benefit From Dependent Eligibility Audits Thanks to New Audit Toolkit 60131 2Syngenta Ventures Invests in U S Biotech Company Metabolon 14601 1Syngenta Ventures Invests in U S Biotech Company Metabolon 14601 2Syngenta Ventures Invests in U S Biotech Company Metabolon 14601 3
...us that has been,specifically designed by scientis...r is showing early promise in a preliminary study,...ano (ECLU),Switzerland. , The virus, called NV102...hat it selectively replicates in virus cells, kill...n normal, healthy cells, so our hope is,that it wi...
...w That Extended,Thromboprophylaxis Reduces VTE Ris...ally Significant 44% , PARIS, July 8, 2007 /PRNews...he results of the EXCLAIM (EXtended CLinical,proph...ch showed,the benefit of extended prophylaxis in a...by demonstrating the superiority of 5 weeks,course...
Other Medicine Technology:MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 2MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 3MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 4MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 5New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 2New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 3New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 4New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 5New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 6
Renu Preservative Free Lubricating and Rewetting Drops
Sterile Preserved Saline Solution
Sensitive Eyes Plus Saline Solution
... have been designed to provide the ophthalmic surg...recise hemostasis. Medtronic recently introduced a...y instruments. These instruments provide discrete ...s or controlled drainage retinotomy, without compr...
Medicine Products: